Yan Zhang

发表

Oxymatrine enhanced anti-tumor effects of Bevacizumab against triple-negative breast cancer via abating Wnt/β-Catenin signaling pathway.

Gang Huang, Yanjuan Huang, Zhaoli Zhou, 2019, American journal of cancer research.

A novel recombinant human Frizzled-7 protein exhibits anti-tumor activity against triple negative breast cancer via abating Wnt/β-catenin pathway.

Gang Huang, Guoqing Wan, Yanjuan Huang, 2018, The international journal of biochemistry & cell biology.

5-Aza-2 ’-deoxycytidine and 5-fluorouracil synergistically induce colon cancer cell apoptosis in a P 53-independent manner

T. Tang, Guang Shan, Yan Zhang, 2016 .

Coumarin-based derivatives with potential anti-HIV activity.

Zhi Xu, Yan Zhang, Qingtai Chen, 2021, Fitoterapia.

Differential expression of CCR8 in tumors versus normal tissue allows specific depletion of tumor-infiltrating T regulatory cells by GS-1811, a novel Fc-optimized anti-CCR8 antibody

Changyun Hu, D. Wiederschain, M. Gostissa, 2022, Oncoimmunology.

TPX2 silencing exerts anti-tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway

Lizhen Liu, Shuang Li, Dan-Hong Huang, 2019, International journal of molecular medicine.

Vascular Normalization Was Associated with Colorectal Tumor Regression upon Anti-PD-L1 Combinational Therapy

S. Qin, Yuhui Huang, Yanhua Yue, 2023, Journal of immunology research.

120 P-MUC1C-ALLO1: An allogeneic car-t for multiple solid tumor indications

E. Ostertag, D. Shedlock, Maximilian Richter, 2020, Journal for ImmunoTherapy of Cancer.

123 P-MUC1C-ALLO1: A fully allogeneic stem cell memory T cell (TSCM) CAR-T therapy with broad potential in solid tumor

E. Ostertag, Yingying Zhao, D. Shedlock, 2021, Journal for ImmunoTherapy of Cancer.

Abstract 4532: Preclinical evaluation of JTX-1811, an anti-CCR8 antibody with enhanced ADCC activity, for preferential depletion of tumor-infiltrating regulatory T cells

Changyun Hu, M. Gostissa, E. Stack, 2020, Immunology.